BASEL LIFE 2018

11–14 September 2018

Congress Center Basel
Switzerland

From personalised to global health

Friday 14 September 2018

10.45 – 17.15

Innovation Forums

From personalised to global health

The organizers of the associated event are Swiss TPH and the Botnar Foundation in co-operation with the Journal Public Health Genomics and the European Alliance for Personalised Medicine.

All partners engage in personalised health and medicine with a global public health and social equity perspective. The Botnar Foundation has an additional focus on children’s health. The partners aim is to improve citizen and patient health across the globe.

Personalised health technology and big data analysis are revolutionising disease control along the chain from etiological research, to prevention, screening, diagnosis and treatment. To translate evidence into patient and citizen access needs adapting R&D, P&R and regulatory processes to novel disease understanding and policy context. Presentations of the workshop will stimulate an exchange on which processes related to the translation of personalised health from bench-to-citizen-to-bedside is right for all diseases and health systems.

Chairs:
Denis Horgan (European Alliance of Personalised Medicine, Brussels, Belgium)
Nicole Probst-Hensch (Epidemiology and Public Health Swiss TPH, Basel, Switzerland)

10.45
Welcome and Moderation
Denis Horgan (European Alliance of Personalised Medicine, Brussels, Belgium)
Nicole Probst-Hensch (Epidemiology and Public Health Swiss TPH, Basel, Switzerland)

10.55
Personalised health innovation in oncology – the case of lung cancer
Kerstin Vokinger (Harvard Medicine School, Boston, United States)

11.20
Personalised Health: A regional perspective
Gianni D'Errico (Toscana Life Sciences Foundation, Florence, Italy)

12.15
Developing new products for vulnerable populations in low income countries – the example of Medicines for Malaria Venture
Joerg Moehrle (Medicines for Malaria Ventures, Geneva, Switzerland)

12.45
Developing new products for vulnerable populations in high income countries – the case of erythropoeitic protoprophyria
Jasmin Barman-Aksözen (Stadtspital Triemli, Zurich, Switzerland)

14.45
Mathematical modelling towards efficient drug development
Melissa Penny (Swiss TPH, Basel, Switzerland)

14.50
Immunological profiling towards personalised vaccines
Claudia Daubenberger (Swiss TPH, Basel, Switzerland)

14.55
Omic profiling towards causal inference in primary prevention
Ayoung Jeong (Swiss TPH, Basel, Switzerland)

15.00
Imanging and biobanking towards understanding the dual disease burden in Laos
Peter Odermatt (Swiss TPH, Basel, Switzerland)

15.05
Drug development for neglected tropical diseases
Jenny Kaiser (Swiss TPH, Basel, Switzerland)

 

Chair:
Juerg Utzinger (Swiss TPH, Basel, Switzerland)

16.15
Panel discussion-Challenges and next steps
Juerg Utzinger (Swiss TPH, Basel, Switzerland)
Marcel Tanner (Swiss TPH, Basel, Switzerland)
Denis Horgan (European Alliance of Personalised Medicine, Brussels, Belgium)
Melissa Penny (Swiss TPH, Basel, Switzerland)
Andrea Zybach (Grossrätin, Bern, Switzerland)

Shanghai 3

Main sponsor(s)

Sponsor(s)